At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 150 enrolled
Drug / intervention
Amitriptyline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Preemptive Analgesia With Amitryptyline for Prevention of Post-operative Pain in Women After Total Abdominal Hysterectomy: a Randomized Clinical Trial
In Brief
A Phase 3 clinical trial evaluating Amitriptyline and Placebo for Pain, Postoperative. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether amitryptyline is effective in the prevention of pain in women after a total abdominal hysterectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesBrazil
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJul 2018
Primary CompletionOct 2018
TodayJul 2026
First PostedJul 16, 2018
Enrollment StartJun 1, 2015
Primary CompletionOct 30, 2018
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 8.0 years ago
Interventions
Amitriptylinedrug
Amitriptyline compared with placebo for preemptive analgesia in women after abdominal hysterectomy.
Placebodrug
Placebo